Cloud Banner

Healthcare

Image

Global Vascular Grafts and Peripheral Stents Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Oct 2023
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Vascular Grafts and Peripheral Stents Market, By Product Type (Vascular Graft and Peripheral Stent), Vascular Graft Raw Material Source (Synthetic, Biosynthetic and Biological), Vascular Graft Indication (Endovascular Aneurysm Repair, Peripheral Vascular Repair and Haemodialysis Access), Peripheral Stent Artery Type (Carotid Artery, Fem-Pop Artery, Iliac Artery and Infrapop Artery), Vascular Graft Application (Coronary Artery Disease, Vascular Occlusion, Aneurysm, Renal Failure and Others), End Users (Hospitals, Ambulatory Surgical Centres, Cardiac Catheterization Laboratories, Specialty Clinics and Others) – Industry Trends and Forecast to 2030.

Vascular Grafts and Peripheral Stents Market

Vascular Grafts and Peripheral Stents Market Analysis and Size

Global Vascular Grafts and Peripheral Stents market has experienced significant growth due to the increasing prevalence of vascular disease Worldwide, over 2 million people receive treatment for dialysis. Around 37 million people in the U.S. and 3 million people are estimated to suffer from CKD.                

Data Bridge Market Research analyses that the global vascular grafts and peripheral stents market which was USD 3,514.12 million in 2022, is expected to reach USD 6,134.12 million by 2030, and is expected to undergo a CAGR of 6.0% during the forecast period of 2023 to 2030. “Vascular Graft” dominates the product type segment of the global vascular grafts and peripheral stents market due to advancements in prenatal imaging and diagnosis. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Vascular Grafts and Peripheral Stents Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Product Type (Vascular Graft and Peripheral Stent), Vascular Graft Raw Material Source (Synthetic, Biosynthetic and Biological), Vascular Graft Indication (Endovascular Aneurysm Repair, Peripheral Vascular Repair and Haemodialysis Access), Peripheral Stent Artery Type (Carotid Artery, Fem-Pop Artery, Iliac Artery and Infrapop Artery), Vascular Graft Application (Coronary Artery Disease, Vascular Occlusion, Aneurysm, Renal Failure and Others), End Users (Hospitals, Ambulatory Surgical Centres, Cardiac Catheterization Laboratories, Specialty Clinics and Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

GSK plc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Astrazeneca (U.S.), Pfizer Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Sanofi (U.S.), Amgen Inc. (U.S.), Daiichi Sankyo Company Limited (Japan), AB Sciences (France), Eisai Co., Ltd (Japan), Genentech Inc. (U.S), Merck & Co., Inc. (U.S.)

Market Opportunities

  • Patient-Tailored Approaches
  • Emerging Markets Expansion
  • Research and Development

Market Definition

Vascular grafts and peripheral stents encompass all aspects of the development, manufacturing, and distribution of vascular grafts and peripheral stents. Vascular grafts are synthetic or biological conduits used to bypass or replace damaged blood vessels, often in procedures such as coronary artery bypass grafting (CABG) and peripheral vascular bypass surgery. Peripheral stents are mesh-like devices inserted into arteries or veins to support vessel walls, maintain blood flow, and treat conditions such as peripheral artery disease (PAD).

Global Vascular Grafts and Peripheral Stents Market Dynamics

Drivers

  • Rising Prevalence of Vascular Diseases

Cardiovascular diseases, including coronary artery disease, peripheral artery disease, and aneurysms, have become a global health challenge. The increasing prevalence of these conditions, driven by factors such as sedentary lifestyles, poor dietary habits, and an aging population, is a significant driver for the global vascular grafts and peripheral stents market.

  • Technological Advancements in Vascular Grafts and Peripheral Stents

Ongoing advancements in medical technologies have transformed the landscape of vascular grafts and peripheral stents. These innovations encompass materials, design, and manufacturing processes, resulting in devices that are more durable, biocompatible, and versatile.

  • Growing Aging Population

The global demographic landscape is shifting, with an increasing aging population. Older adults are more susceptible to various vascular conditions, including cardiovascular disease, atherosclerosis, and aneurysms. The aging population represents a consistent and growing customer base for vascular interventions. Healthcare systems and providers must address the unique healthcare needs of this demographic, leading to an increase in vascular procedures.

Opportunities

  • Patient-Tailored Approaches

The trend toward personalized medicine opens up opportunities for the customization of vascular interventions based on individual patient characteristics. Tailoring grafts and stents to patients' unique anatomies and disease profiles can lead to improved outcomes and reduced complications.

  • Emerging and Markets Expansion

Expanding into emerging markets, particularly in Asia-Pacific and Latin America, offers untapped opportunities for growth. Rising healthcare expenditures, a growing middle-class population, and increasing awareness of vascular diseases drive the demand for advanced medical devices. Entering emerging markets provides access to a new customer base and potential partnerships with local healthcare providers. It also enables companies to diversify their revenue streams.

Restraints/Challenges

  • High Cost of Vascular Interventions

Vascular grafts and peripheral stents can be expensive, especially when combined with associated healthcare costs such as hospitalization, anesthesia, and post-operative care. The high cost of these interventions can limit access, particularly for patients with limited financial resources.

  • Complexity of Disease Management

Vascular diseases often involve intricate and multifaceted disease mechanisms. Understanding and effectively addressing these complexities require substantial research and development efforts. Companies engaged in vascular interventions must invest in research to unravel the intricacies of disease mechanisms. This includes identifying new therapeutic targets and developing innovative treatment approaches. Peripheral artery disease is influenced by a range of factors, including atherosclerosis, inflammation, and lifestyle factors, making it a complex condition to manage.

This global vascular grafts and peripheral stents market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global vascular grafts and peripheral stents market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In September 2021, Terumo Aortic launched PANTHER - a global surgical graft study of knitted and woven surgical grafts. Also, strategies such as mergers & acquisitions, collaborations, and partnerships adopted by key players to expand and strengthen the market are propelling the growth

Global Vascular Grafts and Peripheral Stents Market Scope

The global vascular grafts and peripheral stents market is segmented on the basis of product type, vascular graft raw material source, vascular graft indication, peripheral stent artery type, vascular graft application and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Vascular Graft
  • Peripheral Stent

Vascular Graft Raw Material Source

  • Synthetic
  • Biosynthetic
  • Biological

Vascular Graft Indication

  • Endovascular Aneurysm Repair
  • Peripheral Vascular Repair
  • Haemodialysis Access

Peripheral Stent Artery Type

  • Carotid Artery
  • Fem-Pop Artery
  • Iliac Artery
  • Infrapop Artery

Vascular Graft Application

  • Coronary Artery Disease
  • Vascular Occlusion
  • Aneurysm
  • Renal Failure
  • Others

End Users

  • Hospitals
  • Ambulatory Surgical Centres
  • Cardiac Catheterization Laboratories
  • Specialty Clinics
  • Others

Global Vascular Grafts and Peripheral Stents Market Regional Analysis/Insights

The global vascular grafts and peripheral stents market is analysed and market size insights and trends are provided by country, product type, vascular graft raw material source, vascular graft indication, peripheral stent artery type, vascular graft application and end users as referenced above.

The countries covered in the global vascular grafts and peripheral stents market report are U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the global vascular grafts and peripheral stents market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period of 2023 to 2030, due to the increase in the expenditure for research and development proficiencies, increasing government’s initiatives and improved health care infrastructure in various countries.

Asia-Pacific on the other hand is projected to exhibit the highest growth rate in the global vascular grafts and peripheral stents market during the forecast period of 2023 to 2030 owing to the increasing government expenditure on the healthcare sector and rising technological advancements and initiatives by the government.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The global vascular grafts and peripheral stents market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global vascular grafts and peripheral stents market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global vascular grafts and peripheral stents market. The data is available for historic period 2015-2020.

Competitive Landscape and Global Vascular Grafts and Peripheral Stents Market Share Analysis

The global vascular grafts and peripheral stents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global vascular grafts and peripheral stents market.

Some of the major players operating in the global vascular grafts and peripheral stents market are:

  • GSK plc. (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Novartis AG (Switzerland)
  • Astrazeneca (U.S.)
  • Pfizer Inc. (U.S.)
  • Bristol-Myers Squibb Company (U.S.)
  • Sanofi (U.S.)
  • Amgen Inc. (U.S.)
  • Daiichi Sankyo Company Limited (Japan)
  • AB Sciences (France)
  • Eisai Co., Ltd (Japan)
  • Genentech Inc. (U.S)
  • Merck & Co., Inc. (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The global vascular grafts and peripheral stents market value was USD 3,514.12 million in 2022.
The growth rate of the vascular grafts and peripheral stents market is 6.0% in the forecast period by 2030.
Rising prevalence of vascular diseases & technological advancements in vascular grafts and peripheral stents are the growth drivers of the vascular grafts and peripheral stents market.
Product type, vascular graft raw material source, vascular graft indication, peripheral stent artery type, vascular graft application and end users are the factors on which the vascular grafts and peripheral stents market research is based.
Major companies in the vascular grafts and peripheral stents market are GSK plc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Astrazeneca (U.S.), Pfizer Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Sanofi (U.S.), Amgen Inc. (U.S.), Daiichi Sankyo Company Limited (Japan), AB Sciences (France), Eisai Co., Ltd (Japan), Genentech Inc. (U.S), Merck & Co., Inc. (U.S.)
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials